Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective

Non-small cell lung cancer is a prevalent and rapidly-expanding challenge to modern medicine. While generalized medicine with traditional chemotherapy yielded comparatively poor response rates and treatment results, the cornerstone of personalized medicine using genetic profiling to direct treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wenxiao, Cai, Guiqing, Hu, Peter C., Wang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089847/
https://www.ncbi.nlm.nih.gov/pubmed/30109178
http://dx.doi.org/10.1016/j.apsb.2018.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089847/
https://www.ncbi.nlm.nih.gov/pubmed/30109178
http://dx.doi.org/10.1016/j.apsb.2018.04.005

Ejemplares similares